BHX, a novel pyrazoline derivative, inhibits breast cancer cell invasion by reversing the epithelial-mesenchymal transition and down-regulating Wnt/β-catenin signallingHanmei Bao, Yan Zhao|Scientific Reports|2017Cited by 32
Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling PathwaysZhongling Zhu, Yan Zhao|Frontiers in Pharmacology|2021Cited by 17